@article {Aggarwal2021.10.04.21264524, author = {Nishant Aggarwal and Tamoghna Ghosh and Munish Bhan and Vignesh Dwarakanathan and Prayas Sethi and Ved Prakash Meena and Sanjeev Sinha and Animesh Ray}, title = {Post-tuberculosis sequelae and their correlation with quality of life: An observational study at a tertiary care center of north India}, elocation-id = {2021.10.04.21264524}, year = {2021}, doi = {10.1101/2021.10.04.21264524}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Lung impairment is a frequently recognised outcome in patients treated for pulmonary tuberculosis (TB). The impact of post-TB sequelae is not only restricted to clinical outcomes but also includes the quality of life and psycho-social well-being. However the magnitude of involvement of quality of life and the likely factors determining it are not clear. In this study, we assess the degree of compromise of quality of life and its determinants in patients of post-TB sequelae.Methods Patients \>18 years of age with a history of pulmonary tuberculosis were included in the study. Clinical history, pulmonary function test (PFT) and chest radiographs were recorded. The severity of dyspnea was evaluated using mMRC; quality of life assessment (QoL) was done using two standardized questionnaires- St. George{\textquoteright}s Respiratory Questionnaire (SGRQ) and Seattle Obstructive Lung Disease Questionnaire (SOLQ).Results A total of 90 participants (mean age 40.4{\textpm}11.6 years; 60 [66.7\%] males) were recruited in the study. Overall, 93.3\% (95\% CI: 86.1\%-97.5\%) were currently symptomatic. A total of 96.8\% (61/63) patients had abnormal pulmonary function test results, out of which 61.9\% (39/63) had a mixed type. Out of 65 patients with chest radiographs available, 60 (92.3\%,95\% CI:84.6-96.8) patients had abnormalities with 45 (69.2\%,95\% CI: 58.3-78.2) having bilateral chest radiographic abnormalities. On assessment of QoL by SGRQ, the average score obtained was 42.3{\textpm}24.0 (95\% CI:37.3-47.3), with {\textquoteleft}Symptoms{\textquoteright} being the most affected domain. On using SOLQ, {\textquoteleft}Treatment satisfaction{\textquoteright} (mean score 38.5{\textpm}21.7, 95\% CI:34-43) and {\textquoteleft}Physical function{\textquoteright} (mean score 66.6{\textpm}23.7, 95\% CI:61.6-71.6) were the most affected. Neither spirometry results nor chest radiograph severity score could significantly account for the reduction of QoL. There was also a significant correlation between most of the parameters of SGRQ and SOLQ questionnaires in these patients.Conclusion Persistent respiratory symptoms, radiographic and spirometric abnormalities, were present in most of the patients with post-tubercular sequelae. Quality of life, as measured by SGRQ and SOLQ, was found to be significantly impaired in the majority of patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding is involved.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:institutional medical ethical committee of the All India Institute of Medical Sciences, New Delhi, India All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available on reasonable request.}, URL = {https://www.medrxiv.org/content/early/2021/10/05/2021.10.04.21264524}, eprint = {https://www.medrxiv.org/content/early/2021/10/05/2021.10.04.21264524.full.pdf}, journal = {medRxiv} }